688163: Online roadshow announcement of Salem biology's initial public offering and listing on the science and Innovation Board

Shanghai Sailun Biotechnology Co., Ltd

Initial public offering and listing on the science and Innovation Board

Online roadshow announcement

Sponsor (lead underwriter): Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd

The application of Shanghai Sailun Biotechnology Co., Ltd. (hereinafter referred to as the "issuer") for the initial public offering of RMB common shares (A shares) and listing on the science and Innovation Board (hereinafter referred to as the "issuance") has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, and has been approved and registered by the CSRC's CSRC license [2022] No. 204.

This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance"), and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts market value in Shanghai market (hereinafter referred to as "online issuance"). The issuer and the recommendation institution (lead underwriter) Founder Securities Co.Ltd(601901) underwriting recommendation Co., Ltd. (hereinafter referred to as "recommendation institution (lead underwriter)") will directly determine the issuance price through offline preliminary inquiry, and offline cumulative bidding inquiry will not be conducted.

It is proposed to issue 27.06 million new shares, accounting for 25.00% of the total share capital of the issuer after the issuance. The initial number of strategic placements in this offering is 1353000 shares, accounting for 5.00% of the number of this offering. The difference between the final number of strategic placements and the initial number of strategic placements will be first transferred back to offline issuance. Before the launch of the callback mechanism, the initial number of shares issued offline was 17.995 million, accounting for 70.00% of the number issued after deducting the initial strategic placement, and the initial number of shares issued online was 7.712 million, accounting for 30.00% of the number issued after deducting the initial strategic placement. The total quantity of final offline and online issuance is the total quantity of this issuance minus the final strategic placement quantity. The final quantity of online and offline issuance will be determined according to the callback situation.

In order to facilitate investors to understand the relevant information of the issuer and the relevant arrangements of this issuance, the issuer and the recommendation institution (lead underwriter) of this issuance will hold an online roadshow on this issuance. Please pay attention to it.

1. Online roadshow time: 14:00-17:00 on February 25, 2022 (t-1);

2. Online roadshow website: Shanghai Securities roadshow Center: http://roadshow.sseinfo.com.

China Securities Network: http://roadshow.cn.stock.com.

3. Participants: major members of the board of directors and management of the issuer and relevant personnel of the sponsor (lead underwriter).

The full text of the letter of intent of Shanghai Sailun Biotechnology Co., Ltd. for initial public offering and listing on the science and innovation board and relevant materials can be found on the website of Shanghai Stock Exchange (www.sse. Com. CN) Query. Please pay attention to it.

Issuer: sponsor of Shanghai Sailun Biotechnology Co., Ltd. (lead underwriter): Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd. February 24, 2022 Online roadshow announcement of Shanghai Sailun Biotechnology Co., Ltd. on initial public offering and listing on the science and Innovation Board (seal page)

Shanghai Sailun Biotechnology Co., Ltd. (no text on this page, which is the seal page of the online roadshow announcement of Shanghai Sailun Biotechnology Co., Ltd. on initial public offering and listing on the science and Innovation Board)

Founder Securities Co.Ltd(601901) underwriting and recommendation Co., Ltd. mm / DD / yyyy

- Advertisment -